Retracted: Efficacy, Safety, and Impact on Patient Survival of PDL1/PD-1 Inhibitors versus FOLFIRINOX Regimens for Advanced Pancreatic Cancer

Detalles Bibliográficos
Autor principal: Methods in Medicine, Computational and Mathematical
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322466/
https://www.ncbi.nlm.nih.gov/pubmed/37416243
http://dx.doi.org/10.1155/2023/9849436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322466/
https://www.ncbi.nlm.nih.gov/pubmed/37416243
http://dx.doi.org/10.1155/2023/9849436

Ejemplares similares